We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVDAW icon
326
Iveda Solutions Warrant
IVDAW
$47.8K
$2.17K ﹤0.01%
18,125
– –
KTTAW icon
327
Pasithea Therapeutics Warrants
KTTAW
$5.69K
$845 ﹤0.01%
50,000
– –
TNONW icon
328
Tenon Medical Inc Warrant
TNONW
$1.49K
$414 ﹤0.01%
22,250
– –
ACXP icon
329
Acurx Pharmaceuticals
ACXP
$6.62M
– –
-53,927
Closed -$551K
ADBE icon
330
Adobe
ADBE
$105B
– –
-59,587
Closed -$23.1M
AEMD icon
331
Aethlon Medical
AEMD
$1.66M
– –
-3,700
Closed -$222K
AJG icon
332
Arthur J. Gallagher & Co
AJG
$63.6B
– –
-1,286
Closed -$412K
AMH icon
333
American Homes 4 Rent
AMH
$12.5B
– –
-7,654
Closed -$276K
ANY icon
334
Sphere 3D
ANY
$16M
– –
-199,600
Closed -$1.18M
ARBK
335
Argo Blockchain
ARBK
$42.1M
– –
-20,537
Closed -$830K
AUPH icon
336
Aurinia Pharmaceuticals
AUPH
$2.04B
– –
-1,629,600
Closed -$13.8M
AVPT icon
337
AvePoint
AVPT
$2.71B
– –
-150,000
Closed -$2.9M
AWR icon
338
American States Water
AWR
$3.46B
– –
-2,850
Closed -$218K
AZN icon
339
AstraZeneca
AZN
$250B
– –
-23,500
Closed -$3.28M
BCTXW
340
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
– –
-25,000
Closed -$1.88K
BHVN icon
341
Biohaven
BHVN
$2.21B
– –
-2,136,000
Closed -$31.1M
BIAFW icon
342
bioAffinity Technologies
BIAFW
– –
-204,082
Closed -$26.5K
BJRI icon
343
BJ's Restaurants
BJRI
$1.48B
– –
-50,000
Closed -$2.23M
CAG icon
344
Conagra Brands
CAG
$7.23B
– –
-13,554
Closed -$277K
BNCWW
345
CEA Industries Inc Warrant
BNCWW
– –
-58,333
Closed -$2.16K
CENTA icon
346
Central Garden & Pet Co Class A
CENTA
$2.44B
– –
-324,000
Closed -$10.1M
CLDI icon
347
Calidi Biotherapeutics
CLDI
$1.96M
– –
-4,125
Closed -$182K
CMG icon
348
Chipotle Mexican Grill
CMG
$41.5B
– –
-325,847
Closed -$18.3M
CNSP icon
349
CNS Pharmaceuticals
CNSP
$7.86M
– –
-33,833
Closed -$335K
CPRI icon
350
Capri Holdings
CPRI
$1.74B
– –
-135,000
Closed -$2.39M
12 13
14
15 16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.